Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0287639 CO-ENCAPSULATION OF LIVE CELLS WITH OXYGEN-GENERATING PARTICLES
Microcapsules are described that comprise (a) a liquid aqueous or hydrogel core; (b) a semipermeable membrane surrounding said core; (c) live animal cells...
2016/0287638 ISCHEMIC TOLERANT CELLS AND CELLULAR FACTORS IN THE TREATMENT OF PERIPHERAL ARTERY DISEASE
A method for treatment of peripheral arterial disease conditions comprising systemically administering an effective amount of therapeutic stem cells. Included...
2016/0287637 Synthetic composition and method for modulating emotion and mood disorders
The invention relates to a method for treating or preventing the development of emotion and/or mood disorders in a human individual.
2016/0287636 COMPOSITIONS AND METHODS FOR TREATING A PATHOGENIC METABOLIC CONDITION OF THE GUT MICROBIOTA AND DERIVED DISEASES
The invention relates to the use as a drug or medical nutritional product in humans to treat a pathological dysbiosis and/or to prevent or treat at least one...
2016/0287635 TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS
Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also...
2016/0287634 METHOD OF MANUFACTURING AN AFOD INTRAVENOUS INJECTION FROM FRACTION IV TO PREVENT AND KILL HIV-1 AND HIV-2
The present subject matter relates to a method of manufacturing an AFOD intravenous injection, comprising dissolving a Fraction IV1+IV4 paste with WFI; adding...
2016/0287633 SOLID COMPOSTITIONS BASED ON MINERALS AND ORALLY DISINTEGRATING FORMULATIONS CONTAINING THE SAME
The present invention relates to solid compositions, preferably in powder or granule form, based on minerals (semi-finished or raw material) and a process for...
2016/0287632 PREVENTION OF INFARCT EXPANSION
Provided are methods and kits for safe and effective therapy that can be administered early after a heart attack in order to prevent progressive heart...
2016/0287631 NANOPARTICLE COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TISSUE INFECTIONS AND DISEASES
Stabilized multi-component antimicrobial compositions for treating tissue diseases, infections or conditions include a first and second set of differently...
2016/0287630 COMPOSITIONS AND METHODS FOR COMBATING BACTERIAL INFECTIONS BY KILLING PERSISTER CELLS WITH MITOMYCIN C AND/OR...
The present disclosure provides a method for killing persister cells with mitomycin C and/or cisplatin, or derivatives thereof. Recalcitrant infections are...
2016/0287629 MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF
A composition including a hydrate form of magnesium oxide, denoted as MgO.(H.sub.2O)n, at a concentration ranging from 1 to 100 weight percent (wt %), where n...
2016/0287628 METHOD OF PRODUCING PHYSIOLOGICAL AND THERAPEUTIC LEVELS OF NITRIC OXIDE THROUGH AN ORAL DELIVERY SYSTEM
A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes...
2016/0287627 METHOD FOR SUPPRESSING ONSET OF GASTRIC ULCER AS ADVERSE EFFECT OF DRUG, ORAL PHARMACEUTICAL COMPOSITION FOR...
[Problem] To suppress the onset of adverse effects of drugs that cause gastric ulcers as an adverse effect. [Solution] The onset of gastric ulcers induced by a...
2016/0287626 METHODS OF TREATING AND PREVENTING RADIATION DAMAGE
The invention relates to methods of treating and preventing radiation damage from whole-body exposure. According to the methods of the invention, subjects are...
2016/0287625 METHODS AND MATERIALS FOR TREATING HEMATOLOGICAL MALIGNANCIES
This document provides methods and materials involved in treating hematological malignancies. For example, methods and materials for using telomerase...
2016/0287624 Water-Soluble Vitamins to Increase Oral Absorption and Bioavailability
The present invention provides formulations for enhancing bioavailability of water-soluble compounds including water-soluble vitamins. The formulations include...
2016/0287623 USE OF STING AGONIST AS CANCER TREATMENT
Methods and compositions for treating cancer by intratumorally administering a stimulator of interferon genes (STING) agonist are disclosed herein. In some...
2016/0287622 COMPOSITIONS AND METHODS FOR TREATING IMMUNE AND VIRAL DISORDERS AND MODULATING PROTEIN-RNA INTERACTION
The present invention relates to methods of treating or decreasing the likelihood of developing a disorder associated with immune misregulation, such as, an...
2016/0287621 BIOLOGICAL PRODUCTION OF NAD PRECURSORS AND ANALOGS
Aspects of the invention relate to methods for producing NAD precursors such as nicotinamide mononucleotide (NMN), comprising providing an isolated cell that...
2016/0287620 GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS
A molecule responding to formula (I)of the glycocluster type with galactose residues at their extremities. Simple and efficient methods for the preparation of...
2016/0287619 Synthetic composition for preventing or treating CVD
The invention relates to HMOs and compositions comprising thereof for reducing the risk of, preventing, or treating CVD and/or CDV associated pathological...
2016/0287618 COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF URT INFECTIONS IN INFANTS OR YOUNG CHILDREN AT RISK
The present invention relates to a composition comprising at least one fucosylated oligosaccharide, for use in preventing and/or treating URT infections in an...
2016/0287617 MYCOTOXIN ABSORBENT AND THE USE THEREOF IN BALANCED FOOD FOR ANIMALS
One embodiment relates to a mycotoxin adsorbent highly specific for A and B trichothecenes, and especially for vomitoxin (or deoxinivalenol) and T-2 toxin; as...
2016/0287616 ANTI-FATIGUE COMPOSITION
Compositions and foods which contain (1) histidine and (2) vitamin B6 and/or carnosine are useful for treating, improving, and recovering from fatigue.
2016/0287615 NOVEL ENCAPSULATION OF FLUORESCENT, PHOTO-SENSITIVE, OR OXYGEN-SENSITIVE ACTIVE INGREDIENT FOR TOPICAL APPLICATION
A topical composition for treatment of a skin condition comprising a fluorescent, photosensitive, or oxygen sensitive active ingredient encapsulated in a...
2016/0287614 Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic
The present invention provides a stable, organoleptically acceptable topical formulation(s) of the tetracycline antibiotics or pharmaceutically acceptable...
2016/0287613 SALICYLATES FOR USE IN THE TREATMENT OF CANCER
The present invention relates to salicylates for use in the cancer.
2016/0287612 STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE
The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human,...
2016/0287611 METHODS, COMPOSITIONS, AND FORMULATIONS FOR THE TREATMENT OF THYROID EYE DISEASE
Compositions, formulations, methods, and systems for treating thyroid eye disease and related conditions (e.g., Grave's Ophthalmopathy). The methods described...
2016/0287610 Combination Drug Therapy
A novel combination comprising the 17 .alpha.-hydroxylase/C17,20 lyase inhibitor, (3.beta.)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol or a pharmaceutically...
2016/0287609 ROR GAMMA MODULATORS
The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof, characterized in that at least one of R.sub.8, R.sub.9,...
2016/0287608 Methods for Inhibiting the Development of Huntington's Disease
This invention relates to Huntington's disease and more specifically to methods for inhibiting the development of or treating Huntington's disease by...
2016/0287607 NON-RETINOID ANTAGONISTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE
A method for treating a disease characterized by excessive lipofuscin accumulation in the retina in mammals afflicted therewith, comprising administering to...
2016/0287606 AEROSOL FLUOROQUINOLONE FORMULATIONS FOR IMPROVED PHARMACOKINETICS
The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones...
2016/0287605 COMBINATION THERAPY
A pharmaceutical combination comprising (a) a compound of formula (I), ##STR00001## or pharmaceutically acceptable salts thereof; and (b) one or more at least...
2016/0287604 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), ##STR00001## to methods of...
2016/0287603 USE OF PAR-1 ANTAGONISTS FOR PREVENTING AND/OR TREATING PELVI-PERINEAL FUNCTIONAL PATHOLOGICAL CONDITIONS
The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of ...
2016/0287602 METHODS FOR PROMOTING MOTOR NEURON SURVIVAL
The present invention relates to methods for promoting motor neuron survival, treating or preventing neurodegenerative disorders, identifying agents that...
2016/0287601 ENHANCED TREATMENT REGIMENS USING PI3K INHIBITORS
The present invention provides for methods and pharmaceutical compositions comprising inhibitors of phosphatidylinositol 3-kinases (PI3Ks). In some aspects,...
2016/0287600 COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
A pharmaceutical composition comprising: (a) a compound of formula 1 ##STR00001## wherein: n is 1 or 2; R.sup.1 is hydrogen, halogen, C.sub.1-4-alkyl, or ...
2016/0287599 SUBSTITUTED 1,2,4-TRIAZINE-3,5-DIONES AND THE USE THEREOF AS CHYMASE INHIBITORS
Substituted 1,2,4-triazine-3,5-dione derivatives, processes for their preparation, their use alone or in combinations for the treatment and/or prophylaxis of...
2016/0287598 TRANSVAGINAL PHOSPHODIESTERASE INHIBITORS FOR INFERTILITY TREATMENT
The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the...
2016/0287597 Treatment Regimens Using Multiple Pharmaceutical Agents
The present invention provides for methods and pharmaceutical compositions for treating disorders using treatment regimens involving multiple agents. In one...
2016/0287596 Benzoxazole Kinase Inhibitors and Methods of Use
The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases...
2016/0287595 Combination Pharmaceutical Compositions and Uses Thereof
The present invention provides for methods and pharmaceutical compositions for treating proliferative disorders. In one aspect, the method comprises...
2016/0287594 Compositions Containing Ibrutinib
Discussed herein are pharmaceutical compositions containing Ibrutinib and processes for preparing them. The compositions may be utilized in the treatment of a...
2016/0287593 SILDENAFIL SUBLINGUAL SPRAY FORMULATIONS
The invention is directed to sublingual spray formulations containing sildenafil. The invention is further directed to methods of treating male sexual...
2016/0287592 IBRUTINIB COMBINATION THERAPY
Combinations of Bruton's tyrosine kinase (Btk) inhibitors, e.g., 1-((R)-3-(4-amino-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperid- ...
2016/0287591 METHODS OF ADMINISTERING AN EGFR INHIBITOR
Disclosed are methods of treating a patient having cancer with an EGFR inhibitor requiring an active step of avoiding or modifying the co-administration of...
2016/0287590 3-(SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING...
The invention provides 3-deuterium-enriched 3-(6-, 7-, or 8-substituted-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-diones, deuterated derivatives thereof,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.